317 related articles for article (PubMed ID: 22043825)
1. In vitro properties of platelets stored in three different additive solutions.
Tynngård N; Trinks M; Berlin G
Transfusion; 2012 May; 52(5):1003-9. PubMed ID: 22043825
[TBL] [Abstract][Full Text] [Related]
2. In vitro quality of platelets during prolonged storage after washing with three platelet additive solutions.
Tynngård N; Trinks M; Berlin G
Vox Sang; 2012 Jan; 102(1):32-9. PubMed ID: 21534983
[TBL] [Abstract][Full Text] [Related]
3. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
[TBL] [Abstract][Full Text] [Related]
4. In vitro properties of platelets stored in a small container for pediatric transfusion.
Tynngård N; Trinks M; Berlin G
Transfusion; 2014 Jun; 54(6):1562-8. PubMed ID: 24224557
[TBL] [Abstract][Full Text] [Related]
5. In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days.
Cookson P; Thomas S; Marschner S; Goodrich R; Cardigan R
Transfusion; 2012 May; 52(5):983-94. PubMed ID: 22014032
[TBL] [Abstract][Full Text] [Related]
6. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over.
Sandgren P; Mayaudon V; Payrat JM; Sjödin A; Gulliksson H
Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514
[TBL] [Abstract][Full Text] [Related]
7. In vitro comparison of platelet storage in plasma and in four platelet additive solutions, and the effect of pathogen reduction: a proposal for an in vitro rating system.
van der Meer PF; Kerkhoffs JL; Curvers J; Scharenberg J; de Korte D; Brand A; de Wildt-Eggen J
Vox Sang; 2010 May; 98(4):517-24. PubMed ID: 19930144
[TBL] [Abstract][Full Text] [Related]
8. Platelet activation and residual activation potential during storage of hyperconcentrated platelet products in two different platelet additive solutions.
Vetlesen A; Mirlashari MR; Torsheim IA; Kjeldsen-Kragh J
Transfusion; 2005 Aug; 45(8):1349-55. PubMed ID: 16078925
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of platelet in vitro properties during 7-day storage in M-sol with a 30-hour interruption of agitation.
Wagner SJ; Myrup A; Awatefe H; Thompson-Montgomery D; Hirayama J; Skripchenko A
Transfusion; 2008 Dec; 48(12):2501-607. PubMed ID: 18764828
[TBL] [Abstract][Full Text] [Related]
10. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
[TBL] [Abstract][Full Text] [Related]
11. Platelet ADP response deteriorates in synthetic storage media.
Keuren JF; Cauwenberghs S; Heeremans J; de Kort W; Heemskerk JW; Curvers J
Transfusion; 2006 Feb; 46(2):204-12. PubMed ID: 16441596
[TBL] [Abstract][Full Text] [Related]
12. Parallel comparison of apheresis-collected platelet concentrates stored in four different additive solutions.
Nogawa M; Naito Y; Chatani M; Onodera H; Shiba M; Okazaki H; Matsuzaki K; Satake M; Nakajima K; Tadokoro K
Vox Sang; 2013 Nov; 105(4):305-12. PubMed ID: 23802810
[TBL] [Abstract][Full Text] [Related]
13. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods.
Tynngård N; Lindahl TL; Trinks M; Studer M; Berlin G
Transfusion; 2008 Apr; 48(4):715-22. PubMed ID: 18208416
[TBL] [Abstract][Full Text] [Related]
14. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets.
Ringwald J; Haager B; Krex D; Zimmermann R; Strasser E; Antoon M; De Schrijver E; Eckstein R
Transfusion; 2006 Jun; 46(6):942-8. PubMed ID: 16734810
[TBL] [Abstract][Full Text] [Related]
15. Calcium is a key constituent for maintaining the in vitro properties of platelets suspended in the bicarbonate-containing additive solution M-sol with low plasma levels.
Wagner SJ; Skripchenko A; Myrup A; Thompson-Montgomery D; Awatefe H; Moroff G
Transfusion; 2010 May; 50(5):1028-35. PubMed ID: 20030790
[TBL] [Abstract][Full Text] [Related]
16. In vitro function of platelets treated with ultraviolet C light for pathogen inactivation: a comparative study with nonirradiated and gamma-irradiated platelets.
Tynngård N; Trinks M; Berlin G
Transfusion; 2015 Jun; 55(6):1169-77. PubMed ID: 25524519
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
Vetlesen A; Mirlashari MR; Ezligini F; Kjeldsen-Kragh J
Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
[TBL] [Abstract][Full Text] [Related]
18. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.
Cardigan R; Sutherland J; Garwood M; Bashir S; Turner C; Smith K; Hancock V; Wiltshire M; Pergande C; Williamson LM
Vox Sang; 2008 Feb; 94(2):103-12. PubMed ID: 18034786
[TBL] [Abstract][Full Text] [Related]
19. Storage of platelets in additive solution for up to 12 days with maintenance of good in-vitro quality.
van der Meer PF; Pietersz RN; Reesink HW
Transfusion; 2004 Aug; 44(8):1204-11. PubMed ID: 15265125
[TBL] [Abstract][Full Text] [Related]
20. Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro quality.
Ringwald J; Walz S; Zimmermann R; Zingsem J; Strasser E; Weisbach V; Eckstein R
Vox Sang; 2005 Jul; 89(1):11-8. PubMed ID: 15938735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
